Caricamento...

Randomized Clinical Trial Of Immunogenicity And Safety Of A Recombinant H1N1/2009 Pandemic Influenza Vaccine Containing Advax™ Polysaccharide Adjuvant

BACKGROUND: Timely vaccine supply is critical during influenza pandemics. A recombinant hemagglutinin (rHA)-based vaccine could overcome production hurdles of egg-based vaccines but has never previously been tested in a real-life pandemic setting. The primary aim was to determine the efficacy of a r...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Gordon, David L., Sajkov, Dimitar, Woodman, Richard J., Honda-Okubo, Yoshikazu, Cox, Manon M.J., Heinzel, Susanne, Petrovsky, Nikolai
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2012
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3410954/
https://ncbi.nlm.nih.gov/pubmed/22717330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2012.06.009
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !